Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion type Assertion NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_head.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion description "[NOTCH pathway activation, which occurs frequently in breast cancer, unexpectedly conferred resistance to phosphoinositide 3-kinase (PI3K) inhibitors, which are currently undergoing clinical trials in breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_provenance.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion evidence source_evidence_literature NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_provenance.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion SIO_000772 21946274 NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_provenance.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion wasDerivedFrom befree-2016 NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_provenance.
- NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_assertion wasGeneratedBy ECO_0000203 NP926281.RA-ABSLvrM5Xug0Cte9WhTBFPhuYX_nmHK-MWwiapCErI130_provenance.